Loading clinical trials...
Loading clinical trials...
A Phase II Study on Photodynamic Diagnosis of Urological Cancer in the Upper Urinary Tract Using Fluorescence Endoscopy With Cystoscopy and Ureteroscopy With 5-ALA
Conditions
Interventions
5-Aminolevulinic acid Hydrochloride (Gliolan®)
Locations
1
United States
Henry Ford Hospital
Detroit, Michigan, United States
Start Date
April 1, 2026
Primary Completion Date
December 1, 2027
Completion Date
January 1, 2028
Last Updated
April 1, 2026
NCT06668493
NCT07225374
NCT07126119
NCT02876861
NCT02547350
Lead Sponsor
Henry Ford Health System
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions